Protein Design Labs, Inc.

Develops humanized monoclonals to prevent and treat autoimmune disease, inflammatory conditions, cancers and viral infections. Includes clinical trials in Europe, manufacturing in Minnesota, headquartered in Fremont, California. (Nasdaq: PDLI)